Picture of Nuformix logo

NFX Nuformix Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Nuformix, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
September 30th
2024
September 30th
2025
September 30th
Period Length:12 M12 M18 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.25-1.11-0.859-3.64-0.653
Depreciation
Amortisation
Non-Cash Items0.078-0.141-0.0723.15-0.008
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.237-0.1330.280.1330.017
Change in Accounts Receivable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-0.845-1.35-0.596-0.332-0.615
Capital Expenditures-0.0010
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.04400.050
Sale of Fixed Assets
Cash from Investing Activities0.04400.050
Financing Cash Flow Items-0.0030
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.930.140.2850.150.692
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.13-1.21-0.262-0.1820.077